The Patient Connection

Multiple Sclerosis

RRMS Patients in the USA – Get $50 for a 30 minute survey

RRMS Patients in the USA – Get $50 for a 30 minute survey Hi Everyone The Patients Voice would link to invite you to take part in our latest market research project with relapsing remitting multiple sclerosis patients in the United States of America. The research will take the form of a thirty minute online interview which can be conducted from your own home via the internet. If you do take part we will be delighted to reward you with $50.00 thank you for your time and effort. To qualify for the study you will need to meet at least the following requirements:- • Have been diagnosed with relapsing remitting multiple sclerosis • And have been on your current medication for longer than six months For more information and to register your interest please go to http://www.thepati entsvoice.org/Remi tting_Multiple_Scl erosis_patients_in _the_USA.asp Do let me know if you have any question Best wishes Belinda  (Tuesday Nov 3 | post #1)

Zocor, Simvastatin (generic)

The Patients Voice invites you to take part in a blog about Statins

The Patients Voice invites you to take part in a blog about Statins Dear Friends I would like to take this opportunity to invite you to the latest research blog from The Patients Voice. In this research blog we are finding out the opinions of users of the statin family of medicines. These are commonly used in the treatment of high cholesterol and hypertension. It would be really great if you could have a look at the blog and add your experiences and opinions To go to the blog please click here http://www.thepati entsvoice.org/Stat ins.asp Your help will be really valuable in helping us frame some long term research with statin users. It would be great if you could share the blog with anyone you think might be interested. Please do not hesitate to get in touch if you have any questions Thanks in advance for your assistance Best wishes Belinda Moderator –The Patients Voice  (Aug 3, 2009 | post #1)